7:00 AM GMT, Apr 18, 2011
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact email@example.com.
Sales & Marketing
Human Genome Sciences, GlaxoSmithKline sales and marketing update
In a presentation, Human Genome Sciences said it and partner GlaxoSmithKline launched Benlysta belimumab in the U.S. to treat patients with active, autoantibody-positive systemic lupus
Read the full 254 word article